BIOL - Why BIOLASE Stock Is Getting Obliterated Thursday | Benzinga
BIOLASE Inc (NASDAQ: BIOL) shares are trading lower by 38% to $2.03 Thursday morning after the company announced pricing of a $4.5 million underwritten public offering of Series J Convertible Redeemable Preferred Stock ...